(Q30478126)

5 September 2017

Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers (English)

1 reference

5 September 2017

1 reference

1 reference

1 reference

1 reference

Burger DM

1

1 reference

5 September 2017

Agarwala S

2

1 reference

5 September 2017

Child M

3

1 reference

5 September 2017

Been-Tiktak A

4

1 reference

5 September 2017

Wang Y

5

1 reference

5 September 2017

Bertz R

6

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

Antimicrobial Agents and Chemotherapy

5 September 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

5 September 2017

50

1 reference

5 September 2017

10

1 reference

5 September 2017

3336-3342

1 reference

Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.

5 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Simplifying the treatment of HIV infection with ritonavir-boosted protease inhibitors in antiretroviral-experienced patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Atazanavir: a new protease inhibitor to treat HIV infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Pharmacokinetic enhancement of protease inhibitor therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Principles and practice of HIV-protease inhibitor pharmacoenhancement

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Ritonavir-enhanced pharmacokinetics of nelfinavir/M8 during rifampin use.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Treatment of tuberculosis in HIV-infected patients: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Effect of indinavir on the pharmacokinetics of rifampicin in HIV-infected patients.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1610067

Ritonavir enables combined therapy with rifampin and saquinavir

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17005814

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00461-06

1 reference

5 September 2017

1 reference

5 September 2017

1 reference